While TREM1-expressing myeloid cells have been implicated in a wide variety of both cancer and non-cancer-associated inflammation28, the spectrum of their effector signals in each context, in particular with respect to cancer drug resistance, remains poorly elucidated. Here, TREM1 is linked to cancer.